GPT and hypertensive disorder: Most common treatment-related toxicities were fatigue (71%), hypertension (57%), dysgeusia (52%), diarrhea (48%), nausea (43%), elevated aspartate aminotransferase (38%), elevated alanine aminotransferase (33%), and anorexia (33%) — the majority being grade ≤ 2.